therapeutic antibodies - Robuta Search

https://www.mdpi.com/1999-4923/15/10/2402 Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions Monoclonal therapeutic antibodies have revolutionized the treatment of cancer and other diseases. Fc engineering aims to enhance the effector functions or... therapeutic antibodies fc engineered recent advances https://www.preprints.org/manuscript/202309.0943 Development of Therapeutic Monoclonal Antibodies for the Emerging Arbovirus Infections[v1] |... Antibody-based passive immunotherapy has been used effectively in the therapy and prophylaxis of infectious diseases. Outbreaks of the emerging viral... monoclonal antibodies for the arbovirus infections development therapeutic https://www.biospace.com/emergence-of-therapeutic-trispecific-antibodies Emergence Of Therapeutic Trispecific Antibodies - BioSpace emergence therapeutic antibodies https://pmc.ncbi.nlm.nih.gov/articles/PMC6817047/ Therapeutic monoclonal antibodies and clinical laboratory tests: When, why, and what is expected? -... We herein provide an overview of the clinical laboratory tests that should be performed before, during and after using therapeutic monoclonal antibodies (mAbs)... monoclonal antibodies clinical laboratory https://www.news-medical.net/webinar/Advancing-RSV-research-Expanding-therapeutic-options-with-recombinant-antibodies-and-antigens Advancing RSV research: Expanding therapeutic options with recombinant antibodies and antigens This Webinar will provide a comprehensive overview of RSV, highlighting its epidemiology, clinical manifestations, and associated complications. recombinant antibodies advancing rsv research expanding https://pmc.ncbi.nlm.nih.gov/articles/PMC10936611/ Biparatopic antibodies: therapeutic applications and prospects - PMC Biparatopic antibodies (bpAbs) bind distinct, non-overlapping epitopes on an antigen. This unique binding mode enables new mechanisms of action beyond... therapeutic applications antibodies prospects pmc https://pmc.ncbi.nlm.nih.gov/articles/PMC7894971/ Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies... Association of FcRn molecules to the Fc region of IgG in acidified endosomes and subsequent dissociation of the interaction in neutral pH serum enables IgG... https://www.pasteur.fr/en/press-area/press-documents/sars-cov-2-neutralization-ba1-and-ba2-therapeutic-monoclonal-antibodies?language=fr SARS-CoV-2: neutralization of BA.1 and BA.2 by therapeutic monoclonal antibodies Apr 11, 2022 - The SARS-CoV-2 Omicron BA.1 sublineage has been supplanted in many countries by the BA.2 sublineage. Although Omicron is responsible for less severe forms in... sars cov 2 ba 1 https://informaconnect.com/non-cancer-targets-therapeutic-antibodies/ Novel Non-cancer Targets for Therapeutic Antibodies novel non cancer targets therapeutic https://www.jci.org/assets/233100/powerpoint JCI - Can antibodies with specificity for soluble antigens mimic the therapeutic effects of... https://www.jci.org/assets/233102/powerpoint JCI - Can antibodies with specificity for soluble antigens mimic the therapeutic effects of... https://pmc.ncbi.nlm.nih.gov/articles/PMC7098029/ Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 - PMC A newly identified novel coronavirus (SARS-CoV-2) is causing pneumonia-associated respiratory syndrome across the world. Epidemiology, genomics, and...